Flow Diverting Stent Helps Contain Cerebrovascular Defects
|
By HospiMedica International staff writers Posted on 24 Jul 2018 |

Image: The Surpass Streamline Flow Diverter in proximity to an aneurysm (Photo courtesy of Stryker).
An innovative flow diverter embolization device protects susceptible patients from large and giant brain unruptured aneurysms.
The Stryker (Kalamazoo, MI, USA) Surpass Streamline Flow Diverter is a cobalt chromium braided stent that directs blood flow within an intracranial artery away from a weakened blood vessel sac or aneurysm. The high-mesh density of the braid is achieved by increasing the number of braid wires in concert with device diameter; while the 2 mm device has 48 braided wires, the 3 and 4 mm devices have 72 braided wires, and the 5 mm device has 96 wires, providing a more uniform pore density over different sizes.
Filament sizes change from 25 to 36 mm, depending on the device diameter. The increase in wires maintains consistent density across a range of vessel sizes, thereby facilitating reliable and consistent occlusion of the aneurysm over time, and helping to reduce the risk of a future rupture. In addition, the braid angle is designed to prevent unwanted changes in mesh density around curves and to minimize foreshortening. The Surpass Streamline Flow Diverter is loaded within a 3.7-Fr distal catheter with a pusher catheter and accepts a 0.014-inch micro-guidewire.
Surpass Streamline can be positioned using the Surpass delivery system, designed for consistent deployment; the Halo delivery system, which provides atraumatic access to distal vasculature using an intermediate catheter, improving stent fit and climbing performance; or the Streamline delivery system, which allows it to be repositioned distally or proximally, and to be redeployed until precise placement and enhanced vessel apposition are achieved.
“Surpass Streamline is the first flow diverter indicated for large and giant posterior communicating artery aneurysms; these unruptured aneurysms are more challenging, due to their location and surrounding anatomy,” said professor of radiology and neurological surgery Philip Meyers, MD, of New York Presbyterian/Columbia University Medical Center (NY, USA). “The stent is designed to reliably open and provide consistent mesh density across the neck of the aneurysm to aid in aneurysm occlusion while maintaining perforator artery patency.”
While originally indicated for wide-necked or fusiform aneurysms from the petrous segment to the clinoid segment of the internal carotid artery (ICA), flow diversion today is being more broadly applied to small aneurysms, anterior cerebral artery aneurysms, recurrent aneurysms, and other endoluminal and intra-saccular defects.
The Stryker (Kalamazoo, MI, USA) Surpass Streamline Flow Diverter is a cobalt chromium braided stent that directs blood flow within an intracranial artery away from a weakened blood vessel sac or aneurysm. The high-mesh density of the braid is achieved by increasing the number of braid wires in concert with device diameter; while the 2 mm device has 48 braided wires, the 3 and 4 mm devices have 72 braided wires, and the 5 mm device has 96 wires, providing a more uniform pore density over different sizes.
Filament sizes change from 25 to 36 mm, depending on the device diameter. The increase in wires maintains consistent density across a range of vessel sizes, thereby facilitating reliable and consistent occlusion of the aneurysm over time, and helping to reduce the risk of a future rupture. In addition, the braid angle is designed to prevent unwanted changes in mesh density around curves and to minimize foreshortening. The Surpass Streamline Flow Diverter is loaded within a 3.7-Fr distal catheter with a pusher catheter and accepts a 0.014-inch micro-guidewire.
Surpass Streamline can be positioned using the Surpass delivery system, designed for consistent deployment; the Halo delivery system, which provides atraumatic access to distal vasculature using an intermediate catheter, improving stent fit and climbing performance; or the Streamline delivery system, which allows it to be repositioned distally or proximally, and to be redeployed until precise placement and enhanced vessel apposition are achieved.
“Surpass Streamline is the first flow diverter indicated for large and giant posterior communicating artery aneurysms; these unruptured aneurysms are more challenging, due to their location and surrounding anatomy,” said professor of radiology and neurological surgery Philip Meyers, MD, of New York Presbyterian/Columbia University Medical Center (NY, USA). “The stent is designed to reliably open and provide consistent mesh density across the neck of the aneurysm to aid in aneurysm occlusion while maintaining perforator artery patency.”
While originally indicated for wide-necked or fusiform aneurysms from the petrous segment to the clinoid segment of the internal carotid artery (ICA), flow diversion today is being more broadly applied to small aneurysms, anterior cerebral artery aneurysms, recurrent aneurysms, and other endoluminal and intra-saccular defects.
Latest Surgical Techniques News
- Ultrasound Technology Aims to Replace Invasive BPH Procedures
- Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
- New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
- Robot-Assisted Brain Angiography Improves Procedural Outcomes
- Brain Mapping Technology Enhances Precision in Brain Tumor Resection
- Handheld Robotic System Expands Options for Total Knee Surgery
- VR Experience Reduces Patient Anxiety Before Kidney Stone Procedure
- Injectable Mini Livers Offer Hope for Patients Awaiting Transplant
- Pulsed Field Ablation Technology Cleared in Europe for Persistent AFib
- AI-Powered Imaging Brings Real-Time Margin Clarity to Breast Cancer Surgery
- Minimally Invasive Device Safely Treats Challenging Brain Aneurysms
- Surgical Robot Makes Complex Liver Tumor Surgery Safer and Less Invasive
- Neurostimulation Implant Reduces Seizure Burden in Drug-Resistant Epilepsy
- Minimally Invasive Procedure Effectively Treats Small Kidney Cancers
- Fluorescence Probe Paired with Engineered Enzymes Lights Up Tumors for Easier Surgical Removal
- Novel Hydrogel Could Become Bone Implant of the Future
Channels
Artificial Intelligence
view channelAI Analysis of Pericardial Fat Refines Long-Term Heart Disease Risk
Accurately identifying long-term cardiovascular disease risk in asymptomatic adults remains challenging for clinicians. Missed or underestimated risk delays preventive therapy and increases the chance... Read more
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read moreCritical Care
view channel
Noninvasive Monitoring Device Enables Earlier Intervention in Heart Failure
Hospitalizations for heart failure with preserved ejection fraction (HFpEF) remain common because lung congestion often worsens before symptoms prompt treatment changes. Missed early decompensation... Read more
Automated IV Labeling Solution Improves Infusion Safety and Efficiency
Medication administration in high-acuity settings is often complicated by multiple concurrent infusions, making accurate line identification essential. In a 10-hospital intensive care unit study, 60% of... Read morePatient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel







